Impact

SARC’s mission is to connect individuals and organizations from around the world committed to discovering, developing, and delivering the latest and most promising treatments for sarcoma. The sarcoma research, clinical, and patient communities are geographically scattered and under-resourced. It is essential to share scientific knowledge and advance research for improved treatments to defeat sarcoma. Simply put, SARC drives high-impact, centrally supported collaborations amongst the sarcoma research community.

A Scientist’s Perspective: Why is SARC Needed?

Jonathan Fletcher

Jonathan Fletcher, MD

SARC CHIEF SCIENTIFIC OFFICER

Given the rarity of sarcoma and the many subtypes, no single institution has sufficient patient resources for timely accrual and adequate statistical power to complete trials that will yield meaningful results for a variety of sarcomas.

SARC fosters collaborations among the best minds in the sarcoma field, drawing upon resources at different research institutions in the U.S. and globally. SARC is committed to:

  • Recruiting, supporting, and mentoring tomorrow’s Sarcoma leaders
  • Understanding why new therapies help some people and not others, thereby reducing needless treatment toxicity
  • Identifying and evaluating drugs that target essential biologic functions in sarcoma.

These and other ground-breaking SARC programs are needed to develop effective therapies for sarcoma patients.

SUPPORT OUR WORK

Lara Davis, MD

Knight Cancer Institute, Oregon Health & Science University

Scientific Steering Committee Member

“The SARC Career Development Award supported my early interest in sarcoma research, giving me the flexibility to develop and investigate new Sarcoma treatment options. SARC has been instrumental in my enduring dedication to advancing sarcoma research.”

Adrian Marino-Enriquez, MD, PhD

Brigham and Women’s Hospital, Harvard Medical School

“If I had to pick a single event that has enabled my dedication to sarcoma research, that would be obtaining the SARC Career Development Award.”

Brian Van Tine, MD, PhD

Washington University School of Medicine, St. Louis

“I owe everything to SARC for early support.”

Back to top